Exercise limitation in chronic heart failure: Central role of the periphery

Journal of the American College of Cardiology

Volumn 28, Issue 5, 1996, Pages 1092-1102

  Clark, Andrew L ^a,b   Poole Wilson, Philip A ^a   Coats, Andrew J S ^a  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^b WESTERN INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DYSPNEA; EXERCISE; FATIGUE; HEART FAILURE; HUMAN; LUNG FUNCTION; MUSCLE FUNCTION; PRIORITY JOURNAL; REVIEW; SKELETAL MUSCLE; SYMPTOMATOLOGY;

CHRONIC DISEASE; EXERCISE; EXERCISE THERAPY; FATIGUE; HEART FAILURE, CONGESTIVE; HEMODYNAMIC PROCESSES; HUMANS; LUNG; MUSCLE, SKELETAL; RESPIRATION;

EID: 0030297870     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(96)00323-3     Document Type: Review

References (173)

1. 1. Cowley AJ, Fullwood L, Stainer K, Hampton JR. Exercise tolerance in patients with heart failure - how should it be measured? Eur Heart J 1990;12:50-4.
2. 2. Cohen-Solal A, Zannad F, Kayanakis J-G, Gueret P, Aupetit JF, Kolsky H. Multicentre study of the determination of peak oxygen uptake and ventilatory threshold during bicycle exercise in chronic heart failure. Eur Heart J 1991;12:1055-63.
3. 3. Page E, Cohen-Solal A, Jondeau G, et al. Comparison of treadmill and bicycle exercise in patients with chronic heart failure. Chest 1994;106: 1002-6.
4. 4. Cowley AJ, Fullwood LJ, Muller AF, Stainer K, Skene AM, Hampton JR. Exercise capability in heart failure: is cardiac output important after all? Lancet 1991;337:771-3.
5. 5. Sullivan MJ, Cobb FR. The anaerobic threshold in chronic heart failure. Circulation 1990;81 Suppl II:II-47-58.
6. 6. Weber KT, Janicki JS. Cardiopulmonary Exercise Testing. Philadelphia: W.B. Saunders, 1986:154-5.
7. 7. Hansen JE, Sue DY, Oren A, Wasserman K. Relation of oxygen uptake to work rate in normal men and men with circulatory disorders. Am J Cardiol 1987;59:669-74.
8. 8. Lipkin DP, Canepa-Anson R, Stephens MR, Poole-Wilson PA. Factors determining symptoms in heart failure: comparison of fast and slow exercise tests. Br Heart J 1986;55:439-45.
9. 9. Fink LI, Wilson JR, Ferraro N. Exercise ventilation and pulmonary artery wedge pressure in chronic stable congestive heart failure. Am J Cardiol 1986;57:249-53.
10. 10. Gibbs JSR, Keegan J, Wright C, Fox KM, Poole-Wilson PA. Pulmonary artery pressure changes during exercise and daily activities in chronic heart failure. J Am Coll Cardiol 1990;15:52-61.
11. 11. Bittner V, Weiner DH, Yusuf S, et al., for the SOLVD investigators. Predicton of mortality and morbidity with a 6-minute walk test in patients with left ventricular dysfunction. JAMA 1992;270:1702-7.
12. 12. Clark AL, Sparrow JL, Coats AJS. Muscle fatigue and dyspnoea in chronic heart failure: two sides of the same coin? Eur Heart J 1995;16:49-52.
13. 13. Brown CC Jr, Fry DL, Ebert RV. The mechanics of pulmonary ventilation in patients with heart disease. Am J Med 1954;17:438-46.
14. 14. Anand IA, Ferrari R, Kalra GS, Wahi PL, Poole-Wilson PA, Harris PC. Edema of cardiac origin: studies of body water and sodium, renal function, hemodynamic indexes, and plasma hormones in untreated congestive cardiac failure. Circulation 1989;80:299-305.
15. 15. Anand IS, Veall N, Kalra GS, et al. Treatment of heart failure with diuretics: body compartments, renal function and plasma hormones. Eur Heart J 1989;10:445-50.
16. 16. Weber KT, Wilson JR, Janicki J, Likoff MJ. Exercise testing in the evaluation of the patient with chronic cardiac failure. Am Rev Respir Dis 1984;129 Suppl:S60-2.
17. 17. Franciosa JA, Park M, Levine TB. Lack of correlation between exercise capacity and indexes of resting left ventricular performance in heart failure. Am J Cardiol 1981;47:33-9.
18. 18. Lipkin DP, Poole-Wilson PA. Symptoms limiting exercise capacity in chronic heart failure. BMJ 1986;292:653-5.
19. 19. Massie BM, Kramer B, Haughom F. Acute- and long-term effects of vasodilator therapy on resting and exercise hemodynamics and exercise tolerance. Circulation 1981;64:1218-26.
20. 20. Drexler H, Banhardt U, Meinertz T, Wollschläger H, Lehmann M, Just H. Contrasting peripheral short-term and long-term effects of converting enzyme inhibition in patients with congestive heart failure. A double-blind, placebo-controlled trial. Circulation 1989;79:491-502.
21. 21. Maskin CS, Forman R, Sonnenblick EH, Frishman WH, LeJemtel TH. Failure of dobutamine to increase exercise capacity despite hemodynamic improvement in severe chronic heart failure. Am J Cardiol 1983;51:177-82.
22. 22. Savin WM, Haskell WL, Schroeder JS, Stinson EB. Cardiorespiratory responses of cardiac transplant patients to graded, symptom-limited exercise. Circulation 1980;62:55-60.
23. 23. Sinoway LI, Minitti JR, Davis D, et al. Delayed reversal of impaired vasodilation in congestive heart failure after heart transplantation. Am J Cardiol 1988;61:1076-9.
24. 24. Jondeau G, Katz SD, Zohman L, et al. Active skeletal muscle mass and cardiopulmonary reserve: failure to attain peak aerobic capacity during maximal bicycle exercise in patients with severe congestive heart failure. Circulation 1992;86:1351-6.
25. 25. Packer M. Abnormalities of diastolic function as a potential cause of exercise intolerance in chronic heart failure. Circulation 1990;81 Suppl III:III-78-86.
26. 26. Franciosa JA, Baker BJ, Seth L. Pulmonary versus systemic hemodynamics in determining exercise capacity of patients with chronic left ventricular failure. Am Heart J 1985;110:807-13.
27. 27. Szlachcic J, Massie BM, Kramer BL, Topic N, Tubau J, Correlates and prognostic implication of exercise capacity in chronic congestive heart failure. Am J Cardiol 1985;55:1037-42.
28. 28. Baker BJ, Wilen MM, Boyd CM, Dinh HA, Franciosa JA. Relation of right ventricular ejection fraction to exercise capacity in chronic left ventricular failure. Am J Cardiol 1984;54:596-9.
29. 29. Clark AL, Swan JW, Laney R, Connelly M, Somerville J, Coats AJS. The role of right and left ventricular function in the ventilatory response to exercise in chronic heart failure. Circulation 1994;89:2062-9.
30. 30. Fontan F, Baudet E. Surgical repair of tricuspid atresia. Thorax 1971;26: 240-8.
31. 31. Fontan F, Delville C, Quaegebeur J, et al. Repair of tricuspid atresia in 100 patients. J Thorac Cardiovasc Surg 1983;85:647-60.
32. 32. Buller NP, Poole-Wilson PA. Mechanism of the increased ventilatory response to exercise in patients with chronic heart failure. Br Heart J 1990;63:281-3.
33. 33. Davies SW, Emery TM, Walling MIL, Wannamethee G, Lipkin DP. A critical threshold of exercise capacity in the ventilatory response to exercise in heart failure. Br Heart J 1991;65:179-83.
34. 34. Franciosa JA, Leddy CL, Wilen M, Schwartz DE. Relation between haemodynamic and ventilatory responses in determining exercise capacity in severe congestive heart failure. Am J Cardiol 1984;53:127-34.
35. 35. Higginbotham MB, Morris KG, Conn EH, Coleman RE, Cobb FR. Determinants of variable exercise performance among patients with severe left ventricular dysfunction. Am J Cardiol 1983;51:52-60.
36. 36. Rubin SA, Brown HV. Ventilation and gas exchange during exercise in severe chronic heart failure. Am Rev Respir Dis 1984;129 Suppl:S63-4.
37. 37. Sullivan MJ, Higginbotham MB, Cobb FR. Increased exercise ventilation in patients with chronic heart failure: intact ventilatory control despite haemodynamic and pulmonary abnormalities. Circulation 1988; 77:552-9.
38. 38. Rubin SA, Brown HV, Swan HJC. Arterial oxygenation and arterial oxygen transport in chronic myocardial failure at rest, during exercise and after hydralazine treatment. Circulation 1982;66:143-8.
39. 39. Clark AL, Coats AJS. Usefulness of arterial blood gas estimations during exercise in patients with chronic heart failure. Br Heart J 1994;71:528-30.
40. 40. Chua TP, Clark AL, Amadi A, Coats AJS. Relation between chemosensitivity and the ventilatory response to exercise in chronic heart failure. J Am Coll Cardiol 1996;27:650-7.
41. 41. Metra M, Dei Cas L, Panina G, Visioli O. Exercise hyperventilation in chronic congestive heart failure and its relation to functional capacity and hemodynamics. Am J Cardiol 1992;70:622-8.
42. 42. Wada O, Asanoi H, Miyagi K, et al. Importance of abnormal lung perfusion in excessive exercise ventilation in chronic heart failure. Am Heart J 1993;125:790-8.
43. 43. Weber KT, Kinasewitz GT, Janicki JS, Fishman AP. Oxygen utilisation and ventilation during exercise in patients with chronic cardiac failure. Circulation 1982;65:1213-23.
44. 44. Davies SW, Bailey J, Keegan J, Balcon R, Rudd RM, Lipkin DP. Reduced pulmonary microvascular permeability in severe chronic heart failure. Am Heart J 1992;124:137-42.
45. 45. Puri S, Baker BL, Oakley CM, Hughes JMB, Cleland JGF. Increased alveolar/capillary membrane resistance to gas transfer in patients with chronic heart failure. Br Heart J 1994;72:140-4.
46. 46. Clark AL, Volterrani M, Piepoli M, Poole-Wilson PA, Coats AJS. The influence of stage duration during incremental treadmill exercise on metabolic gas exchange measurements. Eur J Appl Physiol 1996;73:144-8.
47. 47. Rajfer SA, Nemanich JW, Shurman AJ, Rossen JD. Metabolic responses to exercise in patients with heart failure. Circulation 1987;76 Suppl VI:VI-46-53.
48. 48. Clark AL, Coats AJS. Effects of induced changes in anatomical dead space ventilation on the relationship between ventilation and carbon dioxide production in normal man. Eur J Clin Invest 1993;23:428-32.
49. 49. Moore DP, Weston AR, Hughes JMB, Oakley CM, Cleland JGF. Effects of increased inspired oxygen concentrations on exercise performance in chronic heart failure. Lancet 1992;339:850-3.
50. 50. Clark AL, Coats AJS. Exercise hyperventilation in chronic congestive heart failure and its relation to functional capacity and hemodynamics. Am J Cardiol 1993;71:1007-8.
51. 51. Clark AL, Poole-Wilson PA, Coats AJS. The relationship between ventilation and carbon dioxide production in patients with chronic heart failure. J Am Coll Cardiol 1992;20:1326-32.
52. 52. Dunnigan A, Staley NA, Smith SA, et al. Cardiac and skeletal muscle abnormalities in cardiomyopathy: comparison of patients with ventricular tachycardia or congestive heart failure. J Am Coll Cardiol 1987;10:608-18.
53. 53. Lipkin D, Jones D, Round J, Poole-Wilson P. Abnormalities of skeletal muscle in patients with chronic heart failure. Int J Cardiol 1988; 18:187-95.
54. 31P NMR skeletal muscle abnormalities in patients with chronic heart failure. Circulation 1989;80:1338-46.
55. 55. Sullivan MJ, Green HJ, Cobb FR. Skeletal muscle biochemistry and histology in ambulatory patients with long-term heart failure. Circulation 1990;81:518-27.
56. 56. Drexler H, Riede U, Münzel T, König H, Funke E, Just H. Alterations of skeletal muscle in chronic heart failure. Circulation 1992;85:1751-9.
57. 57. Sullivan MJ, Green HJ, Cobb FR. Altered skeletal muscle metabolic response to exercise in chronic heart failure: relation to skeletal muscle aerobic enzyme activity. Circulation 1991;84:1597-1607.
58. 58. Ralston MA, Merola AJ, Leier CV. Depressed aerobic enzyme activity of skeletal muscle in severe chronic heart failure. J Lab Clin Med 1991;117: 370-2.
59. 59. Broqvist M, Dahlström U, Karlsson E, Larsson J. Muscle energy metabolism in severe chronic congestive heart failure - effect of treatment with enalapril. Eur Heart J 1992;13:1217-24.
60. 60. Sylven C, Jansson E, Cederholm T, Hildebrand IL, Beermann B. Skeletal muscle depressed calcium and phosphofructokinase in chronic heart failure are upregulated by captopril - a double-blind, placebo-controlled study. J Intern Med 1991;29:171-4.
61. 61. Norgaard A, Bjerregaard P, Baandrup U, Kjeldsen K, Reske-Nielsen E, Thomsen PE. The concentration of the Na, K-pump in skeletal and heart muscle in congestive heart failure. Int J Cardiol 1990;26:185-90.
62. 62. Sabbah HN, Hansen-Smith F, Sharov VG, et al. Decreased proportion of type I myofibers in skeletal muscle of dogs with chronic heart failure. Circulation 1993;87:1729-37.
63. 63. Buller NP, Jones D, Poole-Wilson PA. Direct measurements of skeletal muscle fatigue in patients with chronic heart failure. Br Heart J 1991;65: 20-4.
64. 64. Minotti JR, Christoph I, Oka R, Weiner MW, Wells L, Massie BM. Impaired skeletal muscle function in patients with congestive heart failure. Relationship to systemic exercise performance. J Clin Invest 1991;88:2077-82.
65. 65. Minotti JR, Pillay P, Chang L, Wells L, Massie BM. Neurophysiological assessment of skeletal muscle fatigue in patients with congestive heart failure. Circulation 1992;86:903-8.
66. 66. Wilson JR, Mancini DM, Simson M. Detection of skeletal muscle fatigue in patients with heart failure using electromyography. Am J Cardiol 1992;70: 488-93.
67. 67. Katz AM, Katz PB. Disease of the heart in works of Hippocrates. Br Heart J 1962;24:256-64.
68. 68. Mancini DM, Walter G, Reichnek N, et al. Contribution of skeletal muscle atrophy to exercise intolerance and altered muscle metabolism in heart failure. Circulation 1992;85:1364-73.
69. 69. Volterrani M, Clark AL, Ludman PF, et al. Determinants of exercise capacity in chronic heart failure. Eur Heart J 1994; 15:801-9.
70. 70. Minotti JR, Pillay P, Oka R, Wells L, Christoph I, Massie BM. Skeletal muscle size: relationship to muscle function in heart failure. J Appl Physiol 1993;75:373-81.
71. 71. Weber KT, Janicki JS. Lactate production during maximal and submaximal exercise in patients with chronic heart failure. J Am Coll Cardiol 1985;6: 717-24.
72. 72. Sullivan MJ, Knight JD, Higginbotham MB, Cobb FR. Relation between central and peripheral hemodynamics during exercise in patients with chronic heart failure. Muscle blood flow is reduced with maintenance of arterial perfusion pressure. Circulation 1989;80:769-81.
73. 73. Hoh H, Taniguchi K, Koike A, Doi M. Evaluation of severity of heart failure using ventilatory gas analysis. Circulation 1990;81 Suppl II:II-31-7.
74. 74. Katz SD, Bleiberg B, Wexler J, Bhargava K, Steinberg JJ, LeJemtel T. Lactate turnover at rest and during submaximal exercise in patients with heart failure. J Appl Physiol 1993;75:1974-9.
75. 75. Wiener DH, Fink LI, Maris J, Jones RA, Chance B, Wilson JR. Abnormal skeletal muscle bioenergetics during exercise in patients with heart failure: role of reduced muscle blood flow. Circulation 1986;73:1127-36.
76. 76. Massie BM, Conway M, Yonge R, et al. Skeletal muscle metabolism in patients with congestive heart failure: relation to clinical severity and blood flow. Circulation 1987;76:1009-19.
77. 31P nuclear magnetic resonance evidence of abnormal skeletal muscle metabolism in patients with congestive heart failure. Am J Cardiol 1987;60:309-15.
78. 78. Mancini DM, Ferraro N, Tuchler M, Chance B, Wilson JR. Detection of abnormal calf muscle metabolism in patients with heart failure using phosphorus-31 nuclear magnetic resonance. Am J Cardiol 1988;62:1234-40.
79. 79. Harris R, Edwards R, Hultman E, Nordesjo L, Nylind B, Sahlin K. The time course of phosphorylcreatine resynthesis during recovery of the quadriceps muscle in man. Eur J Physiol 1976;367:137-42.
80. 31P nuclear magnetic resonance spectroscopy study of leg muscle. Clin Sci 1990;79:583-9.
81. 81. Marie PY, Escanye JM, Brunotte F, et al. Skeletal muscle metabolism in the leg during exercise in patients with congestive heart failure. Clin Sci 1990;78:515-9.
82. 82. Drexler H. Skeletal muscle failure in heart failure. Circulation 1992;85: 1621-23.
83. 83. Wilson JR, Martin JL, Schwartz D, Ferraro N. Exercise intolerance in patients with chronic heart failure: role of impaired nutritive flow to skeletal muscle. Circulation 1984;69:1079-87.
84. 84. Herrlin B, Sylvén C. Increased arterial oxygen content - an important compensatory mechanism in chronic moderate heart failure. Cardiovasc Res 1991;25:384-90.
85. 85. Zelis R, Flaim SF. Alterations in vasomotor tone in congestive heart failure. Prog Cardiovasc Dis 1982;24:437-59.
86. 86. Kubo SH, Rector TS, Bank AJ, Williams RE, Heifertz SM. Endothelium-dependent vasodilation is attenuated in patients with heart failure. Circulation 1991;84:1589-96.
87. 87. Katz SD, Biasucci L, Sabba C, et al. Impaired endothelium-mediated vasodilation in the peripheral vasculature in patients with congestive heart failure. J Am Coll Cardiol 1992;19:918-25.
88. 88. Bank AJ, Rector TS, Burke MN, Tschumperlin LK, Kubo SH. Impaired forearm vasodilation to hyperosmolal stimuli in patients with congestive heart failure secondary to idiopathic dilated cardiomyopathy or to ischemic cardiomyopathy. Am J Cardiol 1992;70:1315-9.
89. 89. Franciosa JA, Goldsmith SR, Cohn JN. Contrasting immediate and long-term effects of isosorbide dinitrate on exercise capacity in congestive heart failure. Am J Cardiol 1980;69:559-66.
90. 90. McMurray JJ, Ray SG, Abdullah I, Dargie HJ, Morton JJ. Plasma endothelin in chronic heart failure. Circulation 1992;85:1374-9.
91. 91. LeJemtel TH, Maskin CS, Lucido D, Chadwick BJ. Failure to augment maximal limb blood flow in response to one-leg versus two-leg exercise in patients with severe heart failure. Circulation 1986;74:245-51.
92. 92. Zelis R, Delea CS, Coleman H, Mason DT. Arterial sodium content in experimental congestive heart failure. Circulation 1970;41:213-6.
93. 93. Lindsay DC, Anand IS, Bennett JG, et al. Ultrastructural analysis of skeletal muscle: microvascular dimensions and basement membrane thickness in chronic heart failure. Eur Heart J 1994;15:1470-6.
94. 94. Wroblewski H, Kastrup J, Norgaard T, Mortensen S-A, Haunso S. Evidence of increased microvascular resistance and arteriolar hyalinosis in skin in congestive heart failure secondary to idiopathic dilated cardiomyopathy. Am J Cardiol 1992;69:769-74.
95. 95. Arnold JMO, Marchiori GE, Imrie JR, Burton GL, Plugfelder PW, Kostuk WJ. Large artery function in patients with chronic heart failure. Studies of brachial artery diameter and hemodynamics. Circulation 1991;84:2418-25.
96. 96. Wilson JR, Martin JL, Ferraro N. Impaired skeletal muscle nutritive flow during exercise in patients with congestive heart failure: role of cardiac pump dysfunction as determined by the effect of dobutamine. Am J Cardiol 1984;53:1308-15.
97. 97. Wilson JR, Mancini DM, Dunkman WB. Exertional fatigue due to skeletal muscle dysfunction in patients with heart failure. Circulation 1993;87: 470-5.
98. 98. Holloszy JO. Adaptations of muscular tissue to training. Prog Cardiovasc Dis 1976;18:445-58.
99. 99. Rifenberick DH, Gamble JG, Max SR. Response of mitochondrial enzymes to decreased muscular activity. Am J Physiol 1973;225:1295-99.
100. 100. Cooksey JD, Reilly P, Brown S, Bomze H, Cryer PE. Exercise training and plasma catecholamines in patients with ischemic heart disease. Am J Cardiol 1978;42:372-6.
101. 101. Hespel P, Lijnen P, Faggard R, et al. Effects of physical endurance training on the plasma renin-angiotensin-aldosterone system in normal man. J Endocrinol 1988;116:443-9.
102. 102. Blackburn G, Gibbons G, Bothe A, Benotti P, Harken D, McEnany T. Nutritional support in cardiac cachexia. J Thorac Cardiovasc Surg 1977;73: 489-96.
103. 103. Carr J, Stevenson L, Waiden J, Heber D. Prevalence and haemodynamic correlates of malnutrition in severe congestive heart failure secondary to ischaemic or idiopathic dilated cardiomyopathy. Am J Cardiol 1989;63: 709-13.
104. 104. Morrison WL, Gibson JNA, Rennie MJ. Skeletal muscle and whole body protein turnover in cardiac cachexia: influence of branched chain amino acid administration. Eur J Clin Invest 1988;18:648-54.
105. 105. Pittman J, Cohen P. The pathogenesis of cardiac cachexia. N Engl J Med 1964;271:403-9, 453-60.
106. 106. Green HJ, Sutton JR, Cymerman A, Young PM, Houston CS. Operation Everest II: adaptations in human skeletal muscle. J Appl Physiol 1989;66: 2454-61.
107. 107. Green HJ, Thomson JA, Daub BD, Ranney DA. Biochemical and histochemical alterations in skeletal muscle in man during a period of reduced activity. Can J Physiol Pharmacol 1980;58:1311-6.
108. 108. Patel A, Razzack Z, Dastir D. Disuse atrophy of human skeletal muscles. Arch Neurol 1969;20:413-21.
109. 109. Holloszy JO, Coyle EF. Adaptations of skeletal muscle to endurance exercise and their metabolic consequences. J Appl Physiol 1984;56:831-8.
110. 110. Ferguson DW, Berg WJ, Sanders JS. Clinical and hemodynamic correlates of sympathetic nerve activity in normal humans and patients with heart failure: evidence from direct microneurographic recordings. J Am Coll Cardiol 1990;16:1125-34.
111. 111. McMurray J, Abdullah I, Dargie HJ, Shapiro D. Increased concentrations of tumour necrosis factor in 'cachectic' patients with severe chronic heart failure. Br Heart J 1991;66:356-8.
112. 112. Levine B, Kalman J, Mayer L, Fillit H, Packer M. Elevated circulating levels of tumour necrosis factor in severe chronic heart failure. N Engl J Med 1990;323:236-41.
113. 113. Swan JW, Walton C, Godsland IF, Clark AL, Coats AJS. Insulin resistance in chronic heart failure. Eur Heart J 1994;15:1528-32.
114. 114. Mohanty PK, Thames MD, Arrowood JA, Sowers JR, McNamara C, Szentpetery S. Impairment of cardiopulmonary baroreflex in cardiac transplantation in humans. Circulation 1987;75:914-21.
115. 115. Ellenbogen KA, Mohanty PK, Szentpetery S, Thames MD. Arterial baroreflex abnormalities in heart failure: reversal after orthotopic cardiac transplantation. Circulation 1989;79:51-8.
116. 116. Smith ML, Ellenbogen KA, Eckberg DL, Szentpetery S, Thames MD. Subnormal heart period variability in heart failure: effect of cardiac transplantation. J Am Coll Cardiol 1989;14:106-11.
117. 117. Guazzi MD, Agostoni P, Perego B, et al. Apparent paradox of neurohormonal axis inhibition after body fluid volume depletion in patients with chronic congestive heart failure and water retention. Br Heart J 1994;72: 534-9.
118. 118. Iaria CT, Jalar UH, Kao FF. The peripheral neural mechanism of exercise hyperpnoea. J Physiol 1959;148:49P-50P.
119. 119. Rowell LB, O'Learly DS. Reflex control of the circulation during exercise: chemoreflexes and mechanoreflexes. J Appl Physiol 1990;69:407-18.
120. 120. McCloskey DI, Mitchell JH. Reflex cardiovascular and respiratory responses originating in exercising muscle. J Physiol 1972;224:173-87.
121. 121. Tallarida G, Baldoni F, Peruzzi G, et al. Cardiorespiratory reflex from muscles during dynamic and static exercise in the dog. J Appl Physiol 1985;58:844-50.
122. 122. Rowell LB. The nature of the exercise stimulus. Acta Physiol Scand 1986;556:7-14.
123. 123. Hultman E, Sjöholm H. Blood pressure and heart rate response to voluntary and nonvoluntary static exercise in man. Acta Physiol Scand 1982;115:499-501.
124. 124. Mark AL, Victor RG, Nerhed C, Wallin BG. Microneurographic studies of the mechanisms of sympathetic nerve responses to static exercise in humans. Circ Res 1985;57:461-9.
125. 125. Gandevia SC, Hobbs SF. Cardiovascular responses to static exercise in man: central and reflex contributions. J Physiol 1990;430:105-17.
126. 126. Piepoli M, Clark A, Volterrani M, Adamopoulos S, Sleight P, Coats AJS. Contribution of muscle afferents to the hemodynamic, autonomic and ventilatory responses to exercise in patients with chronic heart failure. Circulation 1996;93:940-52.
127. 127. Sullivan MJ, Higginbotham MB, Cobb FR. Exercise training in patients with severe left ventricular dysfunction: hemodynamic and metabolic effects. Circulation 1988;78:506-16.
128. 128. Coats AJS, Adamopoulos S, Meyer T, Conway J, Sleight P. Physical training in chronic heart failure. Lancet 1990;335:63-6.
129. 129. Coats AJS, Adamopoulos S, Radaelli A, et al. Controlled trial of physical training in chronic heart failure: exercise performance, hemodynamics, ventilation, and autonomic function. Circulation 1992;85:2119-31.
130. 130. Scalvini S, Marangoni S, Volterrani M, Schema M, Quadri A, Levi GF. Physical rehabilitation in coronary patients who have suffered from episodes of cardiac failure. Cardiology 1992;80:417-23.
131. 131. Ehansi AA. Adaptations to training in patients with exercise-induced left ventricular dysfunction. Adv Cardiol 1986;34:148-55.
132. 132. Minotti JR, Johnson EC, Hudson TL, et al. Skeletal muscle response to exercise training in congestive heart failure. J Clin Invest 1990;86:751-8.
133. 133. Sullivan MJ, Higginbotham MB, Cobb FR. Exercise training in patients with chronic heart failure delays ventilatory anaerobic threshold and improves submaximal exercise performance. Circulation 1989;79:324-9.
134. 134. Adamopoulos S, Coats AJS, Brunotte F, et al. Physical training improves skeletal muscle metabolic abnormalities in patients with chronic heart failure. J Am Coll Cardiol 1993;23:1101-6.
135. 135. Stratton JR, Dunn JF, Adamopoulos S, Kemp GJ, Coats AJS, Rajagopalan B. Training partially reverses skeletal muscle metabolic abnormalities during exercise in heart failure. J Appl Physiol 1994;76:1575-82.
136. 136. Jette M, Heller R, Landry F, Blumchen G. Randomised 4-week exercise program in patients with impaired left ventricular function. Circulation 1991;84:1561-7.
137. 137. Minotti JR, Johnson EC, Hudson TL, et al. Training-induced muscle adaptations are independent of systemic adaptations. J Appl Physiol 1990;68:289-94.
138. 138. Davey P, Meyer T, Coats A, et al. Ventilation in chronic heart failure: effects of physical training. Br Heart J 1992;68:473-7.
139. 139. Kraemer MD, Kubo SH, Rector TS, Brunsvold N, Bank AJ. Pulmonary and peripheral vascular factors are important determinants of peak exercise oxygen uptake in patients with heart failure. J Am Coll Cardiol 1993;21: 641-8.
140. 140. Mancini DM, Ferraro N, Nazzaro D, Chance B, Wilson JR. Respiratory-muscle deoxygenation during exercise in patients with heart failure demonstrated with near-infrared spectroscopy. J Am Coll Cardiol 1991;18: 492-8.
141. 141. Mancini DM, Henson D, LaManca J, Levine S. Respiratory muscle function and dyspnea in patients with chronic congestive heart failure. Circulation 1992;86:909-19.
142. 142. Hammond MD, Bauer KA, Sharp JT, Rocha RD. Respiratory muscle strength in congestive heart failure. Chest 1990;98:1091-4.
143. 143. McParland C, Krishnan B, Wang Y, Gallagher CG. Inspiratory muscle weakness and dyspnea in chronic heart failure. Am Rev Respir Dis 1992;146:467-72.
144. 2, [orthophosphate], and [lactate] at transition from rest to exercise in athletes and non-athletes. Eur J Appl Physiol 1977;36:127-40.
145. 145. Paterson DJ, Robbins PA, Conway J. Changes in arterial plasma potassium and ventilation during exercise in man. Resp Physiol 1989;78:323-30.
146. 146. Rikey M, Nicholls DP, Nugent A-M, et al. Respiratory gas exchange and metabolic responses during exercise in McArdle's disease. J Appl Physiol 1993;75:745-54.
147. 147. Wilson JR, Mancini DM, Ferraro N, Egler J. Effect of dichloroacetate on the exercise performance of patients with heart failure. J Am Coll Cardiol 1988;12:1464-9.
148. + and ventilation during exercise in normal subjects and patients with McArdle's syndrome. J Physiol 1990;429:339-48.
149. 149. Barlow CW, Qayyum MS, Davey PP, Conway J, Paterson DJ, Robbins PA. Effect of physical training on exercise-induced hyperkalemia in chronic heart failure: relation with ventilation and catecholamines. Circulation 1994;89:1144-52.
150. 150. Sjogaard G. Role of exercise-induced potassium fluxes underlying muscle fatigue: a brief review. Can J Physiol Pharmacol 1991;69:238-45.
151. 151. Clark AL, Volterrani M, Cerquetani E, et al. The relationship between arterial potassium and ventilation during exercise in patients with chronic heart failure. J Cardiac Failure 1995;1:133-41.
152. 152. Lewis NP, MacDougall IC, Willis N, Coles GA, Williams JD. Correction of renal anaemia by erythropoietin on physical changes during exercise. Eur J Clin Invest 1993;23:423-7.
153. 153. Clark AL, Piepoli M, Coats AJS. Skeletal muscle and the control of ventilation on exercise: evidence for metabolic receptors. Eur J Clin Invest 1995;25:299-305.
154. 154. Asmussen E, Nielsen M. Experiments on nervous factors controlling respiration and circulation during exercise employing blocking of the blood flow. Acta Physiol Scand 1964;60:103-11.
155. 155. Eiken O, Bjurstedt H. Dynamic exercise in man as influenced by experimental restriction of blood flow in the working muscles. Acta Physiol Scand 1987;131:339-45.
156. 156. Green HJ, Sutton J, Cymerman A, Young PM, Houston CS. Operation Everest II: muscle energetics during maximal exhaustive exercise. J Appl Physiol 1989;66:142-50.
157. 157. Green HJ. Manifestations and sites of neuromuscular fatigue. Biochem Exer 1990;21:13-35.
158. 158. Garner SH, Sutton JR, Burse RL, McComas AJ, Cymerman A, Houston CS. Operation Everest II: neuromuscular performance under conditions of extreme simulated altitude. J Appl Physiol 1990;68:1167-72.
159. 159. Packer M, Carver JR, Rodeheffer RJ, et al., for the PROMISE Study Research Group. Effect of oral milrinone on mortality in severe chronic heart failure. N Engl J Med 1991;325:1468-75.
160. 160. Flosequinan for chronic heart failure. Drugs Ther Bull 1993;31:47-8.
161. 161. The Xamoterol in Severe Heart Failure Study Group. Xamoterol in severe heart failure. Lancet 1990;336:1-6.
162. 162. Cowley AJ, Wynne RD, Swami A, Birkhead J, Senc A, Hampton JR. A comparison of the effects of captopril and flosequinan in patients with severe heart failure. Cardiovasc Drugs Ther 1992;6:465-70.
163. 163. Cohn JN, Archibald DG, Ziesche S, et al. Effects of vasodilator therapy on mortality in chronic congestive heart failure. N Engl J Med 1986;314:1547-52.
164. 164. The CONSENSUS Trial Study Group. Effects of enalapril on mortality in severe congestive heart failure: results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). N Engl J Med 1991;325: 303-10.
165. 165. The SOLVD Investigators. Effects of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med 1991;352:293-302.
166. 166. Cohn JN, Johnson G, Ziesche S, et al. A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure. N Engl J Med 1991;325:303-10.
167. 167. Fonarow GC, Chelimsky-Fallick C, Stevenson LW, et al. Effect of direct vasodilation with hydralazine versus angiotensin-converting enzyme inhibition with captopril on mortality in advanced heart failure: the Hy-C trial. J Am Coll Cardiol 1992;19:842-50.
168. 168. Cohn JN. Statistical significance of Veterans Administration vasodilator heart failure trial results. Am J Cardiol 1990;66:1507-8.
169. 169. Goldstein RE, Boccuzzi SJ, Cruess D, Nattel S; the Adverse Experience Committee; and the Multicenter Diltiazem Postinfarction Research Group. Diltiazem increases late-onset congestive heart failure in postinfarction patients with early reduction in ejection fraction. Circulation 1991;83:52-60.
170. 170. Packer M. Neurohormonal interactions and adaptations in congestive heart failure. Circulation 1988;77:727-30.
171. 171. Coats AJS, Clark AL, Piepoli M, Volterrani M, Poole-Wilson PA. Symptoms and quality of life in heart failure: the muscle hypothesis. Br Heart J 1994;72 Suppl:S36-S39.
172. 2-adrenoceptor agonist, increases skeletal muscle strength in young men. Clin Sci 1992;83:615-21.
173. 173. Coats AJS, Adamopolous S. Physical and pharmacological conditioning in chronic heart failure: a proposal for pulsed inotrope therapy. Postgrad Med J 1991;67Suppl 1:S69-S73.